281 related items for PubMed ID: 6536989
1. [Virilizing congenital adrenal hyperplasia due to 21-hydroxylase deficiency: early diagnosis and response to 2 treatment schedules].
Cattani A, Mahaha D, Michaud P, Rodríguez JA, López JM, García H, Foradori A, Velásquez CG.
Rev Chil Pediatr; 1984; 55(6):374-9. PubMed ID: 6536989
[No Abstract] [Full Text] [Related]
2. [17-hydroxyprogesterone in the diagnosis and treatment of adrenogenital syndrome].
Cassorla F.
Rev Chil Pediatr; 1982; 53(4):295-304. PubMed ID: 7163538
[No Abstract] [Full Text] [Related]
3. [Plasmatic 17-alpha-hydroxyprogesterone in congenital adrenal hyperplasia due to 21 hydroxylase deficiency, treated and untreated].
Loras B, Roux H, Audi-Parera L, David M, Bertrand J.
Biomedicine; 1974 Jul; 21(7):317-22. PubMed ID: 4373095
[No Abstract] [Full Text] [Related]
4. Serum 17-alpha-hydroxyprogesterone, progesterone, estradiol, and testosterone in the diagnosis and management of congenital adrenal hyperplasia.
Lippe BM, LaFranchi SH, Lavin N, Parlow A, Coyotupa J, Kaplan SA.
J Pediatr; 1974 Dec; 85(6):782-7. PubMed ID: 4371221
[No Abstract] [Full Text] [Related]
5. [A case of congenital adrenogenital syndrome].
Sumiya H, Kawamura K, Kataumi Z, Fuse H, Ito H, Shimazaki J.
Hinyokika Kiyo; 1985 Aug; 31(8):1433-9. PubMed ID: 3878668
[Abstract] [Full Text] [Related]
6. [Salivary 17-hydroxyprogesterone concentration in monitoring of the treatment of congenital adrenal hyperplasia].
Arisaka O, Shimura N, Nakayama Y, Arisaka M, Yabuta K.
Dtsch Med Wochenschr; 1988 Dec 09; 113(49):1913-5. PubMed ID: 3197614
[Abstract] [Full Text] [Related]
7. Blood progesterone and 17-hydroxyprogesterone levels and production rates in a boy with virilizing congenital adrenal hyperplasia.
Strott CA, Yoshimi T, Bardin CW, Lipsett MB.
J Clin Endocrinol Metab; 1968 Jul 09; 28(7):1085-8. PubMed ID: 5660261
[No Abstract] [Full Text] [Related]
8. Congenital adrenal hyperplasia: simultaneous determination of plasma aldosterone and 17-hydroxyprogesterone.
Parth K, Zimprich H, Swoboda W, Brunel R, Bohrn E.
Acta Endocrinol (Copenh); 1978 Jan 09; 87(1):148-57. PubMed ID: 202131
[No Abstract] [Full Text] [Related]
9. [Determination of 17-hydroxyprogesterone levels in the treatment of children with the adrenogenital syndrome].
Vavrinec J, Dvorák P, Zizkovský V, Kopecký A, Pospísilová D, Starý J.
Cesk Pediatr; 1983 Sep 09; 38(9):533-6. PubMed ID: 6315246
[No Abstract] [Full Text] [Related]
10. Effect of hydrocortisone dose schedule on adrenal steroid secretion in congenital adrenal hyperplasia.
Winterer J, Chrousos GP, Loriaux DL, Cutler GB.
J Pediatr; 1985 Jan 09; 106(1):137-42. PubMed ID: 3871229
[Abstract] [Full Text] [Related]
11. Molecular testing in congenital adrenal hyperplasia due to 21α-hydroxylase deficiency in the era of newborn screening.
Sarafoglou K, Lorentz CP, Otten N, Oetting WS, Grebe SK.
Clin Genet; 2012 Jul 09; 82(1):64-70. PubMed ID: 21534945
[Abstract] [Full Text] [Related]
12. Response to treatment of congenital adrenal hyperplasia in infancy.
Young MC, Hughes IA.
Arch Dis Child; 1990 Apr 09; 65(4):441-4. PubMed ID: 2346339
[Abstract] [Full Text] [Related]
13. Circadian patterns of plasma cortisol, 17-hydroxyprogesterone, and testosterone in congenital adrenal hyperplasia.
Frisch H, Parth K, Schober E, Swoboda W.
Arch Dis Child; 1981 Mar 09; 56(3):208-13. PubMed ID: 7212759
[Abstract] [Full Text] [Related]
14. The application of a serum 17OH-progesterone radioimmunoassay to the diagnosis and management of congenital adrenal hyperplasia.
Hughes IA, Winter JS.
J Pediatr; 1976 May 09; 88(5):766-73. PubMed ID: 1271137
[Abstract] [Full Text] [Related]
15. [Value of the assay of plasma steroids in the control of congenital adrenal hyperplasia].
Theintz GE, Sizonenko PC.
Arch Fr Pediatr; 1985 Mar 09; 42(3):211-7. PubMed ID: 4004483
[Abstract] [Full Text] [Related]
16. Growth and skeletal maturation in congenital adrenal hyperplasia. Review of 20 cases.
Bailey CC, Komrower GM.
Arch Dis Child; 1974 Jan 09; 49(1):4-7. PubMed ID: 4361889
[No Abstract] [Full Text] [Related]
17. Molecular characterization of a Leydig cell tumor presenting as congenital adrenal hyperplasia.
Solish SB, Goldsmith MA, Voutilainen R, Miller WL.
J Clin Endocrinol Metab; 1989 Dec 09; 69(6):1148-52. PubMed ID: 2555382
[Abstract] [Full Text] [Related]
18. Atrial natriuretic peptide and fludrocortisone therapy in congenital adrenal hyperplasia.
Arisaka O, Hosaka A, Arisaka M, Shimura N, Nakayama Y, Yamashiro Y, Yabuta K.
Acta Paediatr; 1992 Mar 09; 81(3):268-9. PubMed ID: 1387331
[No Abstract] [Full Text] [Related]
19. Diagnosis of congenital adrenal hyperplasia by measurement of plasma 17-hydroxyprogesterone.
Barnes ND, Atherden SM.
Arch Dis Child; 1972 Feb 09; 47(251):62-5. PubMed ID: 4336233
[Abstract] [Full Text] [Related]
20. [Acute complications during treatment of virilizing congenital adrenal hyperplasia deficiency due to 21-hydroxylase].
Job JC, Canlorbe P, Lambertz J, Courouble P, Rossier A.
Ann Pediatr (Paris); 1970 Feb 09; 17(6):426-31. PubMed ID: 5421325
[No Abstract] [Full Text] [Related]
Page: [Next] [New Search]
